Asia Pacific Animal Parasiticides Market

The report "Asia Pacific Animal Parasiticides Market by Type [Ectoparasiticides (Pour-ons & Spot-ons, Dips), Endoparasiticides (Oral liquids, Injectables, Feed Additives), Endectocides], Animal Type (Companion Animals, Livestock), End User - Forecast to 2031" is projected to reach USD 3.20 billion by 2031 from USD 2.26 billion in 2026, at a CAGR of 7.2%.

Browse 320 market data Tables and 70 Figures spread through 380 Pages and in-depth TOC on "Asia Pacific Animal Parasiticides Market, by Type [Ectoparasiticides (Pour-ons & Spot-ons, Dips), Endoparasiticides (Oral liquids, Injectables, Feed Additives), Endectocides], Animal Type (Companion Animals, Livestock), End User - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-animal-parasiticides-market-22398175.html

The market for animal parasiticides in the Asia Pacific region is driven by the large and varied animal population, rising pressure from animal parasites due to climatic factors, and the growing focus on preventive, user-friendly treatment options in key markets such as China, India, Japan, Australia, and South Korea. There is growing collaboration among animal and human healthcare companies, regional manufacturers of animal parasiticides, and veterinary contract development & manufacturing organizations to enhance formulation efficacy, boost production capacity, and align with regulatory requirements. On the other hand, AI-enhanced formulation development, extended-action animal parasiticides, formulation and manufacturing advancements, and automated production in the region will further enhance animal parasiticide efficacy and safety, and the integration of digital farm management and animal parasite monitoring will further enhance agility.

By type, the ectoparasiticides segment accounted for largest market share in 2025.

In the Asia Pacific animal parasiticides market, ectoparasiticides accounted for the largest share in 2025. This is primarily due to the prevalence of ticks, fleas, lice, and mites, which thrive in the region's warm, humid climate. As a result, there is a consistent demand for these products throughout the year. Ectoparasites are also found in domestic and farm animals, thereby expanding the consumer base. Furthermore, easy-to-use forms and long-acting combinations are also fueling the growth of ectoparasiticides.

By end user, veterinary hospitals & clinics are expected to register highest CAGR during forecast period.

Veterinary hospitals and clinics are experiencing the fastest growth, driven by increasing pet ownership and a growing preference for professional veterinary care across the Asia Pacific region. Precise diagnostics, prescription-based parasiticides, and access to higher value advanced treatments are supporting stronger sales in these settings. In addition, the rapid expansion of corporate veterinary chains and investments in modern clinic infrastructure are further accelerating demand for hospital- and clinic-based services.

By region, China accounted for largest market share in 2025.

China represents the largest share in 2025 due to the presence of a large livestock population in Asia Pacific and an emerging pet population in the country, resulting in strong demand for parasiticides for both groups. Furthermore, the country has strong manufacturing capabilities and wide product availability. This makes parasiticides more affordable in the region. This is also boosted by an emerging need for animal control within the country.

Key Market Players

The prominent players in the Asia Pacific animal parasiticides market are Zoetis Services LLC (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco (US), Virbac (France), Ceva (France), Vetoquinol (France), Norbrook (UK), Phibro Animal Health Corporation (US), and Bimeda Corporate (Ireland), among others.

Don’t miss out on business opportunities in Asia Pacific Animal Parasiticides Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com